Histamine differentially interacts with tumor necrosis factor-α and thrombin in endothelial tissue factor induction: The role of c-Jun NH2-terminal kinase

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 11, 2006, Pages 2452-2460

  Steffel, J ^a,b   Arnet, C ^a   Akhmedov, A ^a   Iseli, S M ^a   Luscher T F ^a,b   Tanner, Felix C ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Inflammation; Mitogen activated protein kinase; Signal transduction; Thrombosis; Tissue factor; Vascular cell adhesion molecule 1

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; MEPYRAMINE; MESSENGER RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION;

ACUTE DISEASE; ANTHRACENES; CELL ADHESION; CELLS, CULTURED; CORONARY DISEASE; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEMOSTATICS; HISTAMINE; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, HISTAMINE H1; SIGNAL TRANSDUCTION; SYNDROME; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; VASCULITIS;

EID: 33750086324     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02175.x     Document Type: Article

References (42)

1. Hollis TM, Gallik SG, Orlidge A, Yost JC. Aortic endothelial and smooth muscle histamine metabolism. Relationship to aortic 125I-albumin accumulation in experimental diabetes. Arteriosclerosis 1983; 3: 599-606.
2. Brown MJ, Ind PW, Jenner DA. Platelet histamine. N Engl J Med 1980; 303: 756.
3. Mannaioni PF, Di Bello MG, Masini E. Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997; 46: 4-18.
4. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
5. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
6. Lee M, Sommerhoff CP, von Eckardstein A, Zettl F, Fritz H, Kovanen PT. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Arterioscler Thromb Vasc Biol 2002; 22: 2086-91.
7. Atkinson JB, Harlan CW, Harlan GC, Virmani R. The association of mast cells and atherosclerosis: A morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994; 25: 154-9.
8. Kaartinen M, van der Wal AC, van der Loos CM, Piek JJ, Koch KT, Becker AE, Kovanen PT. Mast cell infiltration in acute coronary syndromes: implications for plaque rupture. J Am Coll Cardiol 1998; 32: 606-12.
9. Laine P, Kaartinen M, Penttila A, Panula P, Paavonen T, Kovanen PT. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation 1999; 99: 361-9.
10. Sasaguri Y, Wang KY, Tanimoto A, Tsutsui M, Ueno H, Murata Y, Kohno Y, Yamada S, Ohtsu H. Role of histamine produced by bone marrow-derived vascular cells in pathogenesis of atherosclerosis. Circ Res 2005; 96: 974-81.
11. Murata Y, Tanimoto A, Wang KY, Tsutsui M, Sasaguri Y, De Corte F, Matsushita H. Granulocyte macrophage-colony stimulating factor increases the expression of histamine and histamine receptors in monocytes/ macrophages in relation to arteriosclerosis. Arterioscler Thromb Vasc Biol 2005; 25: 430-5.
12. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular disease: Molecular mechanisms and clinical implications. Circulation 2006; 113: 722-31.
13. Steffel J, Akhmedov A, Greutert H, Luscher TF, Tanner FC. Histamine induces tissue factor expression: Implications for acute coronary syndromes. Circulation 2005; 112: 341-9.
14. Steffel J, Hermann M, Greutert H, Gay S, Luscher TF, Ruschitzka F, Tanner FC. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation 2005; 111: 1685-9.
15. Tanner FC, Meier P, Greutert H, Champion C, Nabel EG, Luscher TF. Nitric oxide modulates expression of cell cycle regulatory proteins: A cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. Circulation 2000; 101: 1982-9.
16. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: A circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 458-62.
17. Cui MZ, Zhao G, Winokur AL, Laag E, Bydash JR, Penn MS, Chisolm GM, Xu X. Lysophosphatidic acid induction of tissue factor expression in aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2003; 23: 224-30.
18. Liu Y, Pelekanakis K, Woolkalis MJ. Thrombin and TNFalpha synergistically stimulate tissue factor expression in human endothelial cells: Regulation through c-Fos and c-Jun. J Biol Chem 2004; 279: 36142-7.
19. Steffel J, Latini RA, Akhmedov A, Zimmermann D, Zimmerling P, Luscher TF, Tanner FC. Rapamycin, but not FK-506, increases endothelial tissue factor expression: Implications for drug-eluting stent design. Circulation 2005; 112: 2002-11.
20. Steffel J, Akhmedov A, Fahndrich C, Ruschitzka F, Luscher TF, Tanner FC. Differential effect of celecoxib on tissue factor expression in human endothelial and vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 349: 597-603.
21. Shimokawa H, Tomoike H, Nabeyama S, Yamamoto H, Araki H, Nakamura M, Ishii Y, Tanaka K. Coronary artery spasm induced in atherosclerotic miniature swine. Science 1983; 221: 560-2.
22. Asako H, Kurose I, Wolf R, DeFrees S, Zheng ZL, Phillips ML, Paulson JC, Granger DN. Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules. J Clin Invest 1994; 93: 1508-15.
23. Miyazawa N, Watanabe S, Matsuda A, Kondo K, Hashimoto H, Umemura K, Nakashima M. Role of histamine H1 and H2 receptor antagonists in the prevention of intimal thickening. Eur J Pharmacol 1998; 362: 53-59.
24. Bartha K, Brisson C, Archipoff G, de la Salle C, Lanza F, Cazenave JP, Beretz A. Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem 1993; 268: 421-9.
25. Guha M, Mackman N. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 2002; 277: 32124-32.
26. Eto M, Kozai T, Cosentino F, Joch H, Luscher TF. Statin prevents tissue factor expression in human endothelial cells: Role of Rho/Rho-kinase and Akt pathways. Circulation 2002; 105: 1756-9.
27. Lin SJ, Shyue SK, Hung YY, Chen YH, Ku HH, Chen JW, Tam KB, Chen YL. Superoxide dismutase inhibits the expression of vascular cell adhesion molecule-1 and intracellular cell adhesion molecule-1 induced by tumor necrosis factor-alpha in human endothelial cells through the JNK/p38 pathways. Arterioscler Thromb Vasc Biol 2005; 25: 334-40.
28. Yoshizumi M, Fujita Y, Izawa Y, Suzaki Y, Kyaw M, Ali N, Tsuchiya K, Kagami S, Yano S, Sone S, Tamaki T. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells. Exp Cell Res 2004; 292: 1-10.
29. Manning AM, Davis RJ. Targeting JNK for therapeutic benefit: From junk to gold ? Nat Rev Drug Discov 2003; 2: 554-65.
30. Tremoli E, Camera M, Toschi V, Colli S. Tissue factor in atherosclerosis. Atherosclerosis 1999; 144: 273-83.
31. Felmeden DC, Spencer CG, Chung NA, Belgore FM, Blann AD, Beevers DG, Lip GY. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). Am J Cardiol 2003; 92: 400-5.
32. Blann AD, Amiral J, McCollum CN, Lip GY. Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. Atherosclerosis 2000; 152: 29-34.
33. Lim HS, Blann AD, Lip GY. Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: Relationships to cardiovascular disease and risk factor intervention. Circulation 2004; 109: 2524-8.
34. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003; 107: 973-7.
35. Li Y, Chi L, Stechschulte DJ, Dileepan KN. Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha. Microvasc Res 2001; 61: 253-62.
36. Jeannin P, Delneste Y, Gosset P, Molet S, Lassalle P, Hamid Q, Tsicopoulos A, Tonnel AB. Histamine induces interleukin-8 secretion by endothelial cells. Blood 1994; 84: 2229-33.
37. Miki I, Kusano A, Ohta S, Hanai N, Otoshi M, Masaki S, Sato S, Ohmori K. Histamine enhanced the TNF-alpha-induced expression of E-selectin and ICAM-1 on vascular endothelial cells. Cell Immunol 1996; 171: 285-8.
38. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: A mechanism for coronary spasm. Science 1984; 223: 1435-7.
39. Stahli BE, Greutert H, Shaoping M, Graf P, Frischknecht K, Stalder M, Englberger L, Künzli A, Schärer L, Luscher TF, Carrel TP, Tanner FC. Absence of histamine-induced nitric oxide release in the human radial artery: Implications for vasospasm of coronary artery bypass vessels. Am J Physiol -Heart 2006; 290: 1182-9.
40. Oliva PB, Breckinridge JC. Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation 1977; 56: 366-74.
41. Buja LM, Hillis LD, Petty CS, Willerson JT. The role of coronary arterial spasm in ischemic heart disease. Arch Pathol Lab Med 1981; 105: 221-6.
42. Hackett D, Davies G, Chierchia S, Maseri A. Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987; 317: 1055-9.